Delivery Order SPE2DB24D2205-SPE2DB25FEBXB
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,143,237 units of the diabetes medication Glimepiride 4 mg tablets. The delivery order, valued at $5,993.70, is a firm fixed-price contract with a completion date of May 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The contract is part of a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,342.87 and an ultimate completion date of April 30, 2025. The contract is for the supply of 4,568,076,664 tablets of the diabetes medication Glimepiride 1 mg. No set-aside designation is mentioned, indicating this was an open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,604.97 firm fixed-price contract is for the delivery of 4,566,149,248 units of the generic medication glimepiride 2 mg tablets. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $8,550.43 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,455,148 units of the pharmaceutical drug Glimepiride 4 mg tablets in 100-count bottles. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,889.98, is for the delivery of 4,566,736,019 units of the medication Glimepiride 4 mg tablet in bottles of 100. The contract is a firm fixed-price delivery order, with an ultimate completion date of December 17, 2024. This award is part of AmerisourceBergen's...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 2 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $1,451.32 and a period of performance through April 28, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,316.49 Firm Fixed Price Delivery Order covers the supply of 4,567,751,489 units of the generic drug Glimepiride 2 mg tablets. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Glimepiride 2 mg tablets, a prescription medication used to treat type 2 diabetes. The fixed-price contract has a ceiling value of $18,382.09 and a period of performance through January 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,575.07 firm fixed-price delivery order is for 4,567,102,251 units of the drug Glimepiride 4 mg tablets. The contract has an ultimate completion date of January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.72 contract is for the delivery of Glimepiride 4 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...